Thrombosis
From the Journals
DOACs’ safety affirmed in real-world setting
Direct oral anticoagulants were linked with lower bleeding risk, regardless of reason for use. One shone brightest.
News
Lower risk of bleeding with apixaban
Real-world data suggest that apixaban poses a lower risk of bleeding than warfarin, but patients who receive lower doses of apixaban have an...
News
CHMP recommends rVWF for VWD
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for vonicog alfa (...
News
CHMP backs approval of caplacizumab
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of caplacizumab (Cablivi) for the...
From the Journals
New look at ATLAS suggests rivaroxaban may still have role in ACS
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
News
Perioperative RBC transfusions linked to VTE
Patients who receive red blood cell (RBC) transfusions before, during, or immediately after surgery may have an increased risk of venous...
Conference Coverage
Survey reveals patient perceptions of ITP
STOCKHOLM—A new survey has revealed patients’ perceptions of immune thrombocytopenia (ITP) and how the condition impacts their quality of life (...
Conference Coverage
Drug is convenient alternative for PNH, doc says
STOCKHOLM—Results of a phase 3 study suggest the long-acting C5 complement inhibitor ravulizumab produces similar results as eculizumab in...
Conference Coverage
Low vitamin D linked with DVT in lupus patients
AMSTERDAM – A single-center review of thrombotic events in lupus patients showed a doubling of DVT risk when vitamin D levels fell below a certain...
From the Journals
RBC transfusions with surgery may increase VTE risk
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
Conference Coverage
DOAC’s edge over warfarin fades with low adherence
BOSTON –